Hypothermia for Encephalopathy in Low Income Countries-Feasibilty (HELIX-I)
Primary Purpose
Neonatal Encephalopathy
Status
Completed
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Tecotherm-HELIX
Sponsored by
About this trial
This is an interventional treatment trial for Neonatal Encephalopathy focused on measuring Encephalopathy, Newborn, Low and Middle-income countries, Hypothermia
Eligibility Criteria
Inclusion Criteria:
- Age < 6 hours, Birth-weight >1.8, Gestation >36 weeks
- Need for resuscitation at birth and 5 minute Apgar score <6 (in born babies) or Lack of cry by 5 minutes of age (for out-born babies)
- Evidence of encephalopathy on clinical examination
Exclusion Criteria:
- Infants in moribound condition, where death is imminent
- Absent heart rate at 10 minute of age
- Major life threatening congenital malformation
- Lack of cooling equipment
- Lack of parental or physician consent
Sites / Locations
- Manipal Hospital
- Calicut Medical College
- Institute of Child Health, Madras Medical College
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Cooling arm
Arm Description
Whole body cooling to 33 to 34 C rectal temperature
Outcomes
Primary Outcome Measures
Feasibility of cooling
To examine feasibility of whole body cooling within six hours of birth in infants with neonatal encephalopathy
Secondary Outcome Measures
Short term morbidity
Short-term neonatal morbidity - Hypotension requiring inotropes, cardiac arrhythmias (other than bradycardia), coagulopathy/thrombocytopenia requiring blood products, respiratory failure requiring ventilatory support, seizures, and subcutaneous fat necrosis.
Full Information
NCT ID
NCT01760629
First Posted
January 2, 2013
Last Updated
February 20, 2015
Sponsor
Thayyil, Sudhin
Collaborators
Government Medical College, Kozhikode, Institute for Child Health, Madras Medical College, Egmore, Chennai, Wayne State University, Manipal Hospital, India
1. Study Identification
Unique Protocol Identification Number
NCT01760629
Brief Title
Hypothermia for Encephalopathy in Low Income Countries-Feasibilty
Acronym
HELIX-I
Official Title
Hypothermia for Encephalopathy in Low Income Countries-Feasibility
Study Type
Interventional
2. Study Status
Record Verification Date
February 2015
Overall Recruitment Status
Completed
Study Start Date
April 2013 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Thayyil, Sudhin
Collaborators
Government Medical College, Kozhikode, Institute for Child Health, Madras Medical College, Egmore, Chennai, Wayne State University, Manipal Hospital, India
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Whole body cooling improves survival with normal neurological outcome after neonatal encephalopathy in high-income countries. However, cooling equipments used in the high-income countries are expensive and unsuitable for wider use in low and middle-income countries (LMIC). We had previously conducted a randomised controlled trial of whole body cooling using phase changing material in south India. Although cooling was provided, there were wide temperature fluctuations.
Aim: To examine efficacy of the low technology cooling equipment (Tecotherm-HELIX) in administering effective and stable whole body cooling in encephalopathic infants.
Methods: After informed parental consent (and ethical approvals), we will administer 72 hours of whole body cooling (rectal temperature 33 to 34C) to a total 50 encephalopathic infants (aged <6 hours) admitted to the neonatal units at Calicut Medical College and Madras Medical College, over a six month period. To induce cooling, the infants will be kept on the cooling mattress. Temperature will be continuously measured for 80 hours using a rectal probe connected to a digital data logger.
The primary outcome will be the effective cooling time i.e. percentage of time (95% CI) for which the temperature remains between 33 to 340C during the intended cooling period.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neonatal Encephalopathy
Keywords
Encephalopathy, Newborn, Low and Middle-income countries, Hypothermia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
62 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cooling arm
Arm Type
Experimental
Arm Description
Whole body cooling to 33 to 34 C rectal temperature
Intervention Type
Device
Intervention Name(s)
Tecotherm-HELIX
Other Intervention Name(s)
Therapeutic hypothermia, Whole body cooling
Intervention Description
Whole body cooling using Tecotherm-HELIX
Primary Outcome Measure Information:
Title
Feasibility of cooling
Description
To examine feasibility of whole body cooling within six hours of birth in infants with neonatal encephalopathy
Time Frame
72 hours
Secondary Outcome Measure Information:
Title
Short term morbidity
Description
Short-term neonatal morbidity - Hypotension requiring inotropes, cardiac arrhythmias (other than bradycardia), coagulopathy/thrombocytopenia requiring blood products, respiratory failure requiring ventilatory support, seizures, and subcutaneous fat necrosis.
Time Frame
2 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Hour
Maximum Age & Unit of Time
1 Month
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age < 6 hours, Birth-weight >1.8, Gestation >36 weeks
Need for resuscitation at birth and 5 minute Apgar score <6 (in born babies) or Lack of cry by 5 minutes of age (for out-born babies)
Evidence of encephalopathy on clinical examination
Exclusion Criteria:
Infants in moribound condition, where death is imminent
Absent heart rate at 10 minute of age
Major life threatening congenital malformation
Lack of cooling equipment
Lack of parental or physician consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sudhin Thayyil, PhD
Organizational Affiliation
Imperial College London
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Seetha Shankaran, MD
Organizational Affiliation
Wayne State University, Michigan
Official's Role
Principal Investigator
Facility Information:
Facility Name
Manipal Hospital
City
Bangalore
Country
India
Facility Name
Calicut Medical College
City
Calicut
Country
India
Facility Name
Institute of Child Health, Madras Medical College
City
Chennai
Country
India
12. IPD Sharing Statement
Citations:
PubMed Identifier
29637198
Citation
Oliveira V, Kumutha JR, E N, Somanna J, Benkappa N, Bandya P, Chandrasekeran M, Swamy R, Mondkar J, Dewang K, Manerkar S, Sundaram M, Chinathambi K, Bharadwaj S, Bhat V, Madhava V, Nair M, Lally PJ, Montaldo P, Atreja G, Mendoza J, Bassett P, Ramji S, Shankaran S, Thayyil S. Hypothermia for encephalopathy in low-income and middle-income countries: feasibility of whole-body cooling using a low-cost servo-controlled device. BMJ Paediatr Open. 2018 Mar 23;2(1):e000245. doi: 10.1136/bmjpo-2017-000245. eCollection 2018.
Results Reference
derived
Learn more about this trial
Hypothermia for Encephalopathy in Low Income Countries-Feasibilty
We'll reach out to this number within 24 hrs